Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01144273
Other study ID # Protocol ver 1.1
Secondary ID KC/KE-10-0021/FR
Status Recruiting
Phase N/A
First received June 14, 2010
Last updated June 29, 2010
Start date May 2010
Est. completion date October 2010

Study information

Verified date June 2010
Source United Christian Hospital
Contact Wing Yee Lillian Choy, MBBS (HK)
Phone 3513 4245
Email cwy027@ha.org.hk
Is FDA regulated No
Health authority Hong Kong: Ethics Committee
Study type Interventional

Clinical Trial Summary

Randomized double blind placebo controlled trial on transversus abdominus plane block approached from abdominal cavity, in patients undergoing total abdominal hysterectomy.


Description:

Potential advantages compared to percutaneous approach are decrease in risk of visceral injury as it is under direct visual and tactile guidance, ease of approach in obese patients, short theatre time for administration, easy to administer.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date October 2010
Est. primary completion date October 2010
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- ASA physical status I-III

- Age 18 or above

- Scheduled to undergo TAH+/- salpingoophorectomy.

- Scheduled to receive general anaesthesia under standardized anaesthetic regime.

- Comprehends how to use intravenous patient controlled analgesia (IV PCA).

- Is willing to complete the postoperative assessment.

- Understands the nature and purpose of this study and the study procedures and has signed the informed consent form for this study to indicate this understanding.

Exclusion Criteria:

- Known allergy to drugs involved in this study

- Previously taking medications thought to result in opioid tolerance, or analgesics thought to interfere with subsequent opioid requirement.

- Undergoing any procedures in addition to TAH+/- salpingoophorectomy.

- With co-existing pathology resulting in persistent pain requiring analgesics.

- Wound incision extending to supra-umbilical level.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Transversus Abdominis Plane Block From Abdominal Approach

Intervention

Procedure:
Transversus abdominis plane block
This intraabdominal approach to TAP block is being used regularly by gynaecological surgeons in this hospital now. To be performed bilaterally before surgical wound closure by an experienced surgeon who initially undergo initial observation by investigator to ensure uniformity in technique. Local anaesthetic or placebo solution will be injected to TAP with blunt needle from within abdominal cavity under visual and tactile guidance at the triangle of Petit, after feeling one 'pop' through the transversus abdominis muscle to the TAP layer. After careful aspiration to exclude vascular puncture, 1.5mg/kg of 0.5% ropivacaine or 0.3ml/kg of 0.9% saline placebo will be injected to each side slowly while observing for signs of toxicity.

Locations

Country Name City State
Hong Kong Department Of Anaesthesiology, Pain medicine and Operating Services. United Christian Hospital Kwun Tong Kowloon

Sponsors (1)

Lead Sponsor Collaborator
United Christian Hospital

Country where clinical trial is conducted

Hong Kong, 

References & Publications (3)

Bonnet F, Berger J, Aveline C. Transversus abdominis plane block: what is its role in postoperative analgesia? Br J Anaesth. 2009 Oct;103(4):468-70. doi: 10.1093/bja/aep243. — View Citation

Carney J, McDonnell JG, Ochana A, Bhinder R, Laffey JG. The transversus abdominis plane block provides effective postoperative analgesia in patients undergoing total abdominal hysterectomy. Anesth Analg. 2008 Dec;107(6):2056-60. doi: 10.1213/ane.0b013e3181871313. — View Citation

McDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007 Jan;104(1):193-7. Erratum in: Anesth Analg. 2007 May;104(5):1108. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary postoperative 24hr morphine consumption The primary objective of this study is to demonstrate the effectiveness of tranversus abdominis plane block using the intraabdominal approach in reducing postoperative 24 hours morphine consumption after total abdominal hysterectomy (TAH) where time 0 is taken as time of arrival at PACU. 24 hours No
Secondary morphine consumption on arrival to post-anaesthetic care unit(PACU) and 4, 12 and 24 hours after. • Assess and compare the morphine consumption on arrival to post-anaesthetic care unit(PACU) and 4, 12 and 24 hours after. 24hrs No
Secondary Degree on pain according to numerical pain score on arrival to post-anaesthetic care unit(PACU) and 4, 12 and 24 hours after during rest and movement (cough 24hrs No
Secondary incidence of nausea and vomiting 24hours postoperatively No